
|Articles|September 23, 2015
Shaji Kumar on Treatment-Related Adverse Events From Monoclonal Antibodies
Author(s)Shaji Kumar
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
Advertisement
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
The main adverse event that is seen is infusion reactions, Kumar says. These reactions are easily managed and, even so, usually go away on their own.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Verzenio Plus Endocrine Therapy Benefits Survival for Some With Breast Cancer
2
FDA Accepts Application for Padcev Plus Keytruda For Some With Bladder Cancer
3
Stage 1 Multiple Myeloma Treatment Options and Side Effect Management
4
Improving End-of-Life Care: Making Hospice and Home Support Accessible
5





